Next Article in Journal
Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b–4 and/or Gleason 9–10
Previous Article in Journal
A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting
Previous Article in Special Issue
Statins Reduce Hepatocellular Carcinoma Risk in Patients with Chronic Kidney Disease and End-Stage Renal Disease: A 17-Year Longitudinal Study
 
 
Review

Article Versions Notes

Cancers 2022, 14(12), 2973; https://doi.org/10.3390/cancers14122973
Action Date Notes Link
article pdf uploaded. 16 June 2022 14:03 CEST Version of Record https://www.mdpi.com/2072-6694/14/12/2973/pdf-vor
article xml file uploaded 17 June 2022 06:04 CEST Original file -
article xml uploaded. 17 June 2022 06:04 CEST Update https://www.mdpi.com/2072-6694/14/12/2973/xml
article pdf uploaded. 17 June 2022 06:04 CEST Updated version of record https://www.mdpi.com/2072-6694/14/12/2973/pdf
article html file updated 17 June 2022 06:05 CEST Original file -
article html file updated 12 August 2022 20:47 CEST Update https://www.mdpi.com/2072-6694/14/12/2973/html
Back to TopTop